Qiliang Zhou
Overview
Explore the profile of Qiliang Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsumoto Y, Higuchi A, Shiba M, Sasaki K, Saiki T, Honma Y, et al.
Palliat Med Rep
. 2023 Jul;
4(1):169-174.
PMID: 37483881
Background: Palliative chemotherapy is commonly used for advanced cancer patients. The timing of chemotherapy termination is crucial for efforts to maintain quality of life. Patients And Methods: This retrospective study...
2.
Nakano M, Shimada Y, Matsumoto Y, Saiki T, Zhou Q, Sasaki K, et al.
Clin J Gastroenterol
. 2022 Feb;
15(2):413-418.
PMID: 35133626
Neuroendocrine neoplasms of the colon and rectum are colorectal epithelial neoplasms with neuroendocrine differentiation. A platinum regimen used for small cell lung cancer is the currently recommended chemotherapy for gastroenteropancreatic ...
3.
Koseki Y, Kamimura K, Tanaka Y, Ohkoshi-Yamada M, Zhou Q, Matsumoto Y, et al.
World J Clin Cases
. 2021 Nov;
9(30):9182-9191.
PMID: 34786403
Background: Colorectal mucinous adenocarcinoma is a rare subtype of colorectal cancer and is characterized by an abundance of mucin in the tumor. In addition, the colorectal mucinous adenocarcinoma often demonstrates...
4.
Ran Q, Zhou Q, Oda K, Yasue A, Abe M, Ye X, et al.
Front Endocrinol (Lausanne)
. 2020 Dec;
11:609697.
PMID: 33381086
The generation of mature, functional, thyroid follicular cells from pluripotent stem cells would potentially provide a therapeutic benefit for patients with hypothyroidism, but differentiation remains difficult. We earlier reported the...
5.
Chen Y, Chen L, Zhou Q
Herz
. 2020 Oct;
46(Suppl 2):253-264.
PMID: 33095272
Background: Endothelial nitric oxide synthase (eNOS) has been reported to be involved in the atherosclerotic process. A number of studies have investigated the association between eNOS gene polymorphisms and the...
6.
He B, Lu Q, Lang J, Yu H, Peng C, Bing P, et al.
Front Bioeng Biotechnol
. 2020 Aug;
8:897.
PMID: 32850745
Circulating tumor cells (CTCs) derived from primary tumors and/or metastatic tumors are markers for tumor prognosis, and can also be used to monitor therapeutic efficacy and tumor recurrence. Circulating tumor...
7.
Sakai Y, Zhou Q, Matsumoto Y, Saiki T, Moriyama M, Toyama A, et al.
Oncology
. 2020 Aug;
98(11):771-778.
PMID: 32829332
Introduction: Because of the increasing age of the general population, there is an increasing number of older patients with lung cancer. Cancer chemotherapy often causes severe hematological toxicity in older...
8.
Kitahara A, Ran Q, Oda K, Yasue A, Abe M, Ye X, et al.
Cell Rep
. 2020 May;
31(6):107626.
PMID: 32402288
The shortage of donor lungs hinders lung transplantation, the only definitive option for patients with end-stage lung disease. Blastocyst complementation enables the generation of transplantable organs from pluripotent stem cells...
9.
Matsumoto Y, Kimura K, Zhou Q, Sasaki K, Saiki T, Moriyama M, et al.
Mol Clin Oncol
. 2019 Sep;
11(4):383-389.
PMID: 31475066
The number of older patients with esophageal cancer (EC) is increasing due to the population aging and increasing life expectancy. However, no optimal treatment strategy for older patients with EC...
10.
Sasaki K, Zhou Q, Matsumoto Y, Saiki T, Moriyama M, Saijo Y
Intern Med
. 2019 Jun;
58(19):2791-2795.
PMID: 31243213
Two patients underwent hemodialysis. Case 1 with stage IV gastric cancer was treated with reduced doses of capecitabine (1,000 mg/m/day, days 1 to 14) and oxaliplatin (65 mg/m, day 1)....